Professional Documents
Culture Documents
Bio Pharmaceuticals
Bio Pharmaceuticals
Mid 2000: monoclonal antibodies not for therapeutic purposes, nucleic acid
based therapeutics.
Recombinant technology started in the seventies, today, there are 100 products
approved around the world.
The first biopharmaceutical to gain marketing approval was that of humulin
(recombinant human insulin developed and marketed by Genentech and Eli Lilly),
initially approved in the United States in 1982
Approximately 250 million patients had been administered these products and
currently in the region of 1 in 4 new molecular entities approved for medical use
are biopharmaceuticals
Alternative delivery